Joshua Odingo, PhD

VP, Chemistry

Joshua has over 25 years of experience in the drug discovery industry and has held research leadership positions in several pharmaceutical companies. He was previously the Vice President of Chemistry at Mavupharma until its acquisition by AbbVie. Prior to Mavupharma, he spent 8 years as the Director of Chemistry at the Infectious Disease Research Institute (IDRI) on Eli Lilly drug discovery initiatives, was a Senior Scientist and Group Leader at ICOS corporation for 9 years and a scientist at Genentech. He earned his PhD from Columbia University, New York and his BSc degree in Chemistry from University of Nairobi, Kenya.